The skin microbiome is a main actor in inflammatory acne.
Wearing a mask as a protection against COVID-19 infection leads to increased cutaneous inflammation and exacerbation or appearance of acne and rosacea.
To help understanding these pathological mechanisms, Phenocell has developed a unique assay based on activation of inflammation by Cutibacterium acnes in human sebocytes derived from iPSC (https://phenocell.com/dermo-cosmetics/acne-oily-skin). The pro-inflammatory response is followed at gene and protein levels and can be completed with analysis of sebum production.
The iPSC technology allows modulation of sebocyte phototype to better approach ethnic (African, Caucasian, Asian) variations to skin inflammation.
Read the complete ZOOM#18 : ZOOM#18-Microbiota-Preclinical-testing.web
Léonard Raimbault
Business Developper
Tel: 06 01 81 50 98
leonard.raimbault@phenocell.com
Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…
26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…
This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…